Current Opinion in Lipidology volume 28, issue 5, P427-433 2017 DOI: 10.1097/mol.0000000000000441 View full text
|
|
Share
Lina Badimon, Teresa Padró, Judit Cubedo

Abstract: The identification of the specific changes in HDL-associated proteins that contribute to the increased cardiovascular risk of familial hypercholesterolemia patients could be useful for the development of novel therapeutic targets. These novel strategies, in combination with current lipid-lowering therapies, may help to reduce the residual risk found in these patients.